Trifluridine/Tipiracil Plus Bevacizumab Improves Survival in Patients With mCRC
Pharma & biotech2018-06-26
14 Views
Patients with metastatic colorectal cancer who are not eligible for chemotherapy or surgical resection may have a new first-line treatment option.
Source: OncLive
The news, reports, views and opinions of authors (or source) expressed are their own and do not necessarily represent the views of CRWE World.
ChoiceTrade Holdings Launches Equity Crowdfunding Campaign to Expand Product and Service Offerings
**Disclaimer:The news, reports, views and opinions expressed by the Crowdfunding Platforms that are advertised at crweworld.com are their own and do not necessarily represent the views of CRWE World. Crown Equity Holdings Inc. has received $2,000.00 (two thousand dollars) in cash for 30 days of advertisement services for ChoiceTrade Holdings from Wallstreet Equities Ltd.
